Research Index
FOXO4-DRI Research Index
PSI surfaces 12 peer-reviewed studies on FOXO4-DRI, prioritized by evidence strength: human clinical research first, then animal studies. The full historical archive is linked below on PubMed.
Sort
Type
Condition
12 studies
Targeting the FOXO4-p53 axis by retro-inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline.
Alameen AAM, Al-Kuraishy HM, Fawzy MN et al.
Naunyn Schmiedebergs Arch Pharmacol·2026·Review·PubMed →
FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway.
Hu Z, Li F, Hu C et al.
Front Bioeng Biotechnol·2025·Animal